Fig 2A and 2B illustrate that Girdin expression varies with tumor grade and cancer stage. Kaplan-Meier survival analysis further demonstrated that elevated Girdin expression is significantly associated with poor OS in LIHC patients (Fig 2C). This evidence concerns the gene CCDC88A and neoplasm.